心臟去顫器市場規模、佔有率、成長分析，按類型、按患者類型、按最終用戶、按地區 - 行業預測，2025 年至 2032 年

預計心臟去顫器市場規模將在 2023 年達到 151 億美元，並從 2024 年的 163.2 億美元成長到 2032 年的 304.4 億美元，預測期內（2025-2032 年）的複合年成長率為 8.1%。

心臟設備市場的成長得益於技術進步、心臟麻痹發生率的增加、公眾意識的增強以及政府和醫療保健組織的舉措。值得注意的是，快速反應復興研究有限公司 (Rapid Response Revival Research Ltd.) 的首款個人家用自動體外心臟心臟去顫器(AED) CellAED 已獲得 CE 認證，符合公司的擴大策略。儘管治療方法不斷進步，心臟麻痹仍然是心血管死亡的主要原因，推動了植入式心臟整流去顫器(ICD) 和外部 AED 的創新和需求。 Ami Italia 等公司提供各種多功能心臟去顫器，而微創醫療已成為中國心律管理領域的領導者，報告指出 2022 年上半年收益成長了 95%。在杜拜 AED 分銷和培訓計劃等舉措的推動下，新興市場的認知度不斷提高，預計將推動市場持續成長。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析
• 技術分析
• 案例研究
• 專利分析

心臟去顫器市場規模（按類型）

• 市場概況
• 植入式心臟整流去顫器
  • 經靜脈植入式心臟整流去顫器
  • 皮下植入式心臟整流去顫器
• 體外心臟去顫器
  • 手動和半自動體外電擊器
  • 全自動體外電擊器
  • 心臟去顫器

心臟去顫器市場規模（依患者類型）

• 市場概況
• 成人
• 孩子們

心臟去顫器市場規模（按最終用戶分類）

• 市場概況
• 醫院、診所和心臟中心
• 院前護理
• 公共接取市場
• 居家照護
• 替代護理設施
• 其他最終用戶

心臟去顫器市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Medtronic（Ireland）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Koninklijke Philips NV（Netherlands）
• ZOLL Medical Corporation（Asahi Kasei）（USA/Japan）
• Nihon Kohden Corporation（Japan）
• Stryker（USA）
• BIOTRONIK SE & Co. KG（Germany）
• MicroPort Scientific Corporation（China）
• Schiller AG（Switzerland）
• Mindray Medical International Ltd.（China）
• Defibtech LLC（USA）
• LivaNova PLC（UK）
• Cardiac Science Corporation（USA）
• Bexen Cardio（Spain）
• Physio-Control Inc.（USA）
• CU Medical Systems Co., Ltd.（South Korea）
• Metrax GmbH（Germany）
• BPL Medical Technologies（India）
• Avive Solutions Inc.（USA）

結論和建議

Defibrillator Market size was valued at USD 15.1 billion in 2023 and is poised to grow from USD 16.32 billion in 2024 to USD 30.44 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The growth of the cardiac device market is fueled by advancements in technology, rising incidences of sudden cardiac arrest, heightened public awareness, and initiatives from government and healthcare organizations. Notably, Rapid Response Revival Research Ltd. received CE certification for CellAED, the first home-use personal AED, aligning with their expansion strategy. Despite treatment advancements, sudden cardiac arrest remains a leading cause of cardiovascular mortality, driving innovation and demand for implantable cardioverter-defibrillators (ICDs) and external AEDs. Companies like Ami Italia offer a range of versatile defibrillators, while Microport has emerged as a leader in China's cardiac rhythm management sector, reporting a 95% revenue increase in H1 2022. Growing awareness in developing markets, bolstered by initiatives such as Dubai's AED distribution and training programs, promises continued market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Defibrillator market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Defibrillator Market Segments Analysis

Global Defibrillator Market is segmented by Type, Patients type, End Users and region. Based on Type, the market is segmented into Implantable cardioverter defibrillators and External defibrillators. Based on Patients type, the market is segmented into Adult and Pediatrics. Based on End Users, the market is segmented into Hospitals, Clinics and Cardiac centres, Pre-hospital care settings, Public access markets, Home care settings, Alternate care facilities and Other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Defibrillator Market

The defibrillator market is significantly driven by the rising prevalence of cardiovascular diseases, including coronary artery disease and cardiac arrest, which pose a major health risk to populations globally. In the United States alone, the CDC reported around 695,000 deaths from cardiovascular diseases in 2021, with coronary artery disease notably increasing the likelihood of sudden cardiac deaths due to arrhythmias. Furthermore, the Coronary Artery Disease Foundation highlighted that approximately 356,000 out-of-hospital cardiac arrests occur annually in the country. Contributing factors such as obesity, hypertension, dyslipidemia, diabetes, and an aging population exacerbate this issue, as older individuals face higher risks of developing serious heart-related conditions and arrhythmias, fueling the demand for defibrillators in healthcare settings.

Restraints in the Defibrillator Market

The defibrillator market faces certain restraints primarily due to the high costs associated with advanced models such as implantable cardioverter defibrillators (ICDs) and other sophisticated devices. These financial constraints can hinder their widespread adoption, especially in areas where healthcare budgets are constrained or insurance coverage is insufficient. As a result, the elevated price of these critical medical devices poses a significant challenge, restraining overall market growth and limiting access for healthcare providers and patients in need of these life-saving technologies. Addressing this cost barrier is essential for fostering greater adoption and improving patient outcomes in various regions.

Market Trends of the Defibrillator Market

The defibrillator market is experiencing a significant surge driven by rapid technological advancements focused on improving device performance and patient outcomes. Innovations such as AI algorithms enhance precision in detecting cardiac rhythms, thereby increasing the likelihood of successful resuscitation. Additionally, the integration of wireless connectivity facilitates remote monitoring and data transmission, allowing healthcare providers to make informed decisions in real-time. User interface enhancements are also making defibrillators more intuitive, thereby reducing the learning curve for operators. As a result, the market is trending towards more sophisticated, user-friendly, and interconnected devices, ultimately contributing to enhanced patient care and overall public health outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies
• Patent Analysis

Global Defibrillator Market Size by Type & CAGR (2025-2032)

• Market Overview
• Implantable cardioverter defibrillators
  • Transvenous implantable cardioverter defibrillators
  • Subcutaneous implantable cardioverter defibrillators
• External defibrillators
  • Manual & semi-automated external defibrillators
  • Fully automated external defibrillators
  • Wearable cardioverter defibrillators

Global Defibrillator Market Size by Patients type & CAGR (2025-2032)

• Market Overview
• Adult
• Pediatrics

Global Defibrillator Market Size by End Users & CAGR (2025-2032)

• Market Overview
• Hospitals, Clinics and Cardiac centres
• Pre-hospital care settings
• Public access markets
• Home care settings
• Alternate care facilities
• Other end users

Global Defibrillator Market Size & CAGR (2025-2032)

• North America (Type, Patients type, End Users)
  • US
  • Canada
• Europe (Type, Patients type, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Patients type, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Patients type, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Patients type, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZOLL Medical Corporation (Asahi Kasei) (USA/Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTRONIK SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schiller AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Defibtech LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiac Science Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bexen Cardio (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Physio-Control Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CU Medical Systems Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Metrax GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BPL Medical Technologies (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avive Solutions Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations